• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流行耐药菌株引起的细菌性感染全景图。

Panorama of Bacterial Infections Caused by Epidemic Resistant Strains.

机构信息

Laboratory of Immunopathology Keizo Asami (LIKA), Federal University of Pernambuco (UFPE), Av. Prof. Moraes Rego, 1235, Cidade Universitária, Recife, PE, CEP: 50670-901, Brazil.

Laboratory of Microbiology and Immunology, Academic Center of Vitória (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão, Rua Do Alto Do Reservatório S/N, Bela Vista, Vitória de Santo Antão, Pernambuco, CEP: 55608-680, Brazil.

出版信息

Curr Microbiol. 2022 Apr 30;79(6):175. doi: 10.1007/s00284-022-02875-9.

DOI:10.1007/s00284-022-02875-9
PMID:35488983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9055366/
Abstract

Antimicrobial resistance (AMR) represents a critical obstacle to public health worldwide, due to the high incidence of strains resistant to available antibiotic therapies. In recent years, there has been a significant increase in the prevalence of resistant epidemic strains, associated with this, public health authorities have been alarmed about a possible scenario of uncontrolled dissemination of these microorganisms and the difficulty in interrupting their transmission, as nosocomial pathogens with resistance profiles previously considered sporadic. They become frequent bacteria in the community. In addition, therapy for infections caused by these pathogens is based on broad-spectrum antibiotic therapy, which favors an increase in the tolerance of remaining bacterial cells and is commonly associated with a poor prognosis. In this review, we present the current status of epidemic strains of methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus (VRE), MDR Mycobacterium tuberculosis, extended-spectrum β-lactamase-producing Enterobacterales (ESBL), Klebsiella pneumoniae carbapenemase (KPC), and-New Delhi Metallo-beta-lactamase-producing Pseudomonas aeruginosa (NDM).

摘要

抗微生物药物耐药性(AMR)代表了全球公共卫生的一个重大障碍,因为存在大量对现有抗生素治疗方法具有耐药性的菌株。近年来,耐药性流行菌株的患病率显著增加,与此相关的是,公共卫生当局对这些微生物可能出现失控传播以及难以中断其传播的情况感到震惊,因为先前被认为是散发性的具有耐药谱的医院病原体成为社区中常见的细菌。此外,由这些病原体引起的感染的治疗基于广谱抗生素治疗,这有利于增加剩余细菌细胞的耐受性,并且通常与预后不良相关。在这篇综述中,我们介绍了耐甲氧西林金黄色葡萄球菌(MRSA)、万古霉素耐药肠球菌(VRE)、耐多药结核分枝杆菌、产超广谱β-内酰胺酶的肠杆菌科(ESBL)、产碳青霉烯酶肺炎克雷伯菌(KPC)和产新德里金属β-内酰胺酶的铜绿假单胞菌(NDM)等流行菌株的现状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/b02d07366249/284_2022_2875_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/63fbdb8825a5/284_2022_2875_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/e821ee42857a/284_2022_2875_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/525d3bb06a3b/284_2022_2875_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/b02d07366249/284_2022_2875_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/63fbdb8825a5/284_2022_2875_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/e821ee42857a/284_2022_2875_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/525d3bb06a3b/284_2022_2875_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7179/9055366/b02d07366249/284_2022_2875_Fig4_HTML.jpg

相似文献

1
Panorama of Bacterial Infections Caused by Epidemic Resistant Strains.流行耐药菌株引起的细菌性感染全景图。
Curr Microbiol. 2022 Apr 30;79(6):175. doi: 10.1007/s00284-022-02875-9.
2
The interface between COVID-19 and bacterial healthcare-associated infections.新冠病毒与细菌所致的医疗保健相关性感染的界面。
Clin Microbiol Infect. 2021 Dec;27(12):1772-1776. doi: 10.1016/j.cmi.2021.06.001. Epub 2021 Jun 7.
3
Bloodstream Infections in the Intensive Care Unit: a Single-Center Retrospective Bacteriological Analysis Between 2007 and 2019.重症监护病房血流感染:2007 年至 2019 年单中心回顾性细菌学分析。
Pol J Microbiol. 2022 Jun 19;71(2):263-277. doi: 10.33073/pjm-2022-025.
4
Prevalence of methicillin resistant , multidrug resistant and extended spectrum β-lactamase producing gram negative bacilli causing wound infections at a tertiary care hospital of Nepal.尼泊尔一家三级护理医院伤口感染的耐甲氧西林、多药耐药和产超广谱 β-内酰胺酶革兰氏阴性杆菌的流行情况。
Antimicrob Resist Infect Control. 2018 Oct 8;7:121. doi: 10.1186/s13756-018-0408-z. eCollection 2018.
5
Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.住院儿童中的多重耐药菌:一项为期5年的多中心研究。
Pediatrics. 2007 Apr;119(4):e798-803. doi: 10.1542/peds.2006-1384.
6
Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.2011-2018 年波兰大学重症监护病房医源性感染相关的微生物因素特征,包括多药耐药病原体和抗生素使用情况。
Int J Environ Res Public Health. 2020 Sep 23;17(19):6943. doi: 10.3390/ijerph17196943.
7
Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility.2008 年日本化疗学会进行的细菌呼吸道病原体全国监测:病原体对抗菌药物敏感性的总体观察。
J Infect Chemother. 2011 Aug;17(4):510-23. doi: 10.1007/s10156-011-0214-5. Epub 2011 Mar 17.
8
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.台湾地区耐甲氧西林金黄色葡萄球菌和表型非超广谱β-内酰胺酶产生肺炎克雷伯菌临床分离株对头孢洛林的敏感性:2012-2018 年抗菌药物测试领导和监测(ATLAS)和 2018-2019 年台湾多中心抗菌药物耐药监测(SMART)的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):106016. doi: 10.1016/j.ijantimicag.2020.106016. Epub 2020 May 15.
9
Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibility.2009 年,由日本化疗学会、日本传染病学会和日本临床微生物学会监测委员会进行的全国细菌性呼吸道病原体监测:病原体抗菌敏感性的总体情况。
J Infect Chemother. 2012 Oct;18(5):609-20. doi: 10.1007/s10156-012-0434-3. Epub 2012 Jul 6.
10
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens.熟练护理机构居民对抗菌药物耐药病原体的定植。
J Am Geriatr Soc. 2001 Mar;49(3):270-6. doi: 10.1046/j.1532-5415.2001.4930270.x.

引用本文的文献

1
National Update on Healthcare-Associated Infections in Iran for 2023-Based on the Iranian Nosocomial Infections Surveillance (INIS) System.基于伊朗医院感染监测(INIS)系统的2023年伊朗医疗保健相关感染全国最新情况。
J Epidemiol Glob Health. 2025 Sep 9;15(1):114. doi: 10.1007/s44197-025-00462-2.
2
Clinical Characteristics and Independent Risk Factors for Multidrug-Resistant Bloodstream Infections: A Retrospective Analysis from China.耐多药血流感染的临床特征及独立危险因素:一项来自中国的回顾性分析
Infect Drug Resist. 2025 Aug 10;18:3993-4006. doi: 10.2147/IDR.S535018. eCollection 2025.
3
Antimicrobial and Antifungal Action of Biogenic Silver Nanoparticles in Combination with Antibiotics and Fungicides Against Opportunistic Bacteria and Yeast.

本文引用的文献

1
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.美国传染病学会关于治疗产 AmpC β-内酰胺酶肠杆菌科、耐碳青霉烯类鲍曼不动杆菌和嗜麦芽窄食单胞菌感染的指南。
Clin Infect Dis. 2022 Jul 6;74(12):2089-2114. doi: 10.1093/cid/ciab1013.
2
Meropenem/vaborbactam activity : a new option for carbapenemase (KPC)-producing treatment.美罗培南/法硼巴坦活性:产碳青霉烯酶(KPC)治疗的新选择。
Future Microbiol. 2021 Nov;16:1261-1266. doi: 10.2217/fmb-2021-0007. Epub 2021 Oct 22.
3
生物源银纳米颗粒与抗生素和杀真菌剂联合对机会性细菌和酵母的抗菌和抗真菌作用
Int J Mol Sci. 2024 Nov 21;25(23):12494. doi: 10.3390/ijms252312494.
4
The influence of marine fungal meroterpenoid meroantarctine A toward HaCaT keratinocytes infected with Staphylococcus aureus.海洋真菌混合二萜类化合物 meroterpenoid meroantarctine A 对感染金黄色葡萄球菌的 HaCaT 角质形成细胞的影响。
J Antibiot (Tokyo). 2024 Dec;77(12):812-822. doi: 10.1038/s41429-024-00771-x. Epub 2024 Sep 10.
5
A retrospective analysis of the 5-year trends of antimicrobial resistance in gram-negative bacterial isolates from an intensive care unit at a tertiary care hospital.对一家三级护理医院重症监护病房革兰氏阴性菌分离株的抗菌药物耐药性5年趋势进行回顾性分析。
Int J Crit Illn Inj Sci. 2023 Oct-Dec;13(4):178-183. doi: 10.4103/ijciis.ijciis_30_23. Epub 2023 Dec 26.
6
New Cyclopiane Diterpenes and Polyketide Derivatives from Marine Sediment-Derived Fungus KMM 4670 and Their Biological Activities.海洋沉积物来源真菌 KMM 4670 的新环巴坪二萜和聚酮衍生物及其生物活性。
Mar Drugs. 2023 Nov 9;21(11):584. doi: 10.3390/md21110584.
7
Innovative Phospholipid Carriers: A Viable Strategy to Counteract Antimicrobial Resistance.创新型磷脂载体:克服抗菌药物耐药性的可行策略。
Int J Mol Sci. 2023 Nov 3;24(21):15934. doi: 10.3390/ijms242115934.
8
Synthesis, Antimicrobial and Antibiofilm Activities, and Molecular Docking Investigations of 2-(1-Indol-3-yl)-1-benzo[]imidazole Derivatives.2-(1-吲哚-3-基)-1-苯并[]咪唑衍生物的合成、抗菌和抗生物膜活性及分子对接研究。
Molecules. 2023 Oct 14;28(20):7095. doi: 10.3390/molecules28207095.
9
The Prevalence of Metallo-Beta-Lactamese-(MβL)-Producing Isolates in Brazil: A Systematic Review and Meta-Analysis.巴西产金属β-内酰胺酶(MβL)分离株的患病率:系统评价与荟萃分析
Microorganisms. 2023 Sep 21;11(9):2366. doi: 10.3390/microorganisms11092366.
10
Rapid Detection of bla in Carbapenem-Resistant Enterobacterales Based on CRISPR/Cas13a.基于 CRISPR/Cas13a 的碳青霉烯类耐药肠杆菌科细菌 bla 快速检测
Curr Microbiol. 2023 Sep 22;80(11):352. doi: 10.1007/s00284-023-03457-z.
Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms.
评估广泛耐药革兰氏阴性菌中阿兹隆胺和头孢他啶-阿维巴坦联合治疗的药敏试验方法。
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0084621. doi: 10.1128/AAC.00846-21. Epub 2021 Aug 23.
4
Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?新冠疫情期间出现的抗菌药物耐药性威胁:我们处于何种境地?
J Infect Public Health. 2021 May;14(5):555-560. doi: 10.1016/j.jiph.2021.02.011. Epub 2021 Mar 5.
5
Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.尿路感染分离株中的肺炎克雷伯菌碳青霉烯酶(KPC)。
Arch Microbiol. 2021 May;203(4):1825-1831. doi: 10.1007/s00203-020-02161-x. Epub 2021 Jan 28.
6
Risk factors and outcomes associated with vancomycin-resistant Enterococcus faecium and ampicillin-resistant Enterococcus faecalis bacteraemia: A 10-year study in a tertiary-care centre in Mexico City.耐万古霉素粪肠球菌和耐氨苄西林粪肠球菌菌血症的相关危险因素和结局:墨西哥城一家三级医疗中心的 10 年研究。
J Glob Antimicrob Resist. 2021 Mar;24:198-204. doi: 10.1016/j.jgar.2020.12.005. Epub 2020 Dec 24.
7
The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA-Salvaging the Gold Standards with Combination Therapy.耐甲氧西林金黄色葡萄球菌中万古霉素和达托霉素敏感性的不断下降——用联合疗法挽救金标准
Antibiotics (Basel). 2020 Oct 30;9(11):762. doi: 10.3390/antibiotics9110762.
8
Evolving trends of New Delhi Metallo-betalactamse (NDM) variants: A threat to antimicrobial resistance.新德里金属-β-内酰胺酶(NDM)变体的演变趋势:对抗菌药物耐药性的威胁。
Infect Genet Evol. 2020 Dec;86:104588. doi: 10.1016/j.meegid.2020.104588. Epub 2020 Oct 8.
9
Successful Development of Bacteriocins into Therapeutic Formulation for Treatment of MRSA Skin Infection in a Murine Model.成功将细菌素开发为治疗制剂,用于治疗小鼠模型中的耐甲氧西林金黄色葡萄球菌皮肤感染。
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.00829-20.
10
Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria.头孢他啶美罗培南复方制剂(cefiderocol)对多重耐药革兰氏阴性菌的活性。
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.01582-20.